Chemexpress(SH:688131) Zheng Quan Zhi Xing·2025-06-20 12:42Group 1 - The company Shanghai Haoyuan Chemexpress Co., Ltd. is issuing convertible bonds amounting to 822.35 million yuan with a maturity of 6 years, starting from December 4, 2024, to November 27, 2030 [3][4][22] - The bond has a face value of 100 yuan per bond, with a tiered interest rate starting at 0.20% in the first year and increasing to 2.00% in the sixth year [5][22] - The initial conversion price for the bonds is set at 40.73 yuan, which may be adjusted based on specific corporate actions such as stock dividends or capital increases [7][9] Group 2 - The company reported a revenue of 227.02 million yuan for the year, reflecting a 20.75% increase compared to the previous year [22] - The total assets of the company reached 550.49 million yuan, marking a 31.31% increase year-over-year [22] - The company has a net profit attributable to shareholders of 0.96 yuan per share, which is a 57.38% increase from the previous year [22] Group 3 - The company focuses on providing CRO and CDMO services for the pharmaceutical and biopharmaceutical industries, with a strong emphasis on small molecule drug development [20][21] - It has established a comprehensive service platform covering the entire drug development process from starting materials to commercial production [21] - The company has approximately 13,000 global partners, showcasing its extensive network and market reach [20]